Purpose and Editorial Scope
SHIZAM® is an independent, documentation-focused knowledge framework. We organize complex clinical, scientific, and regulatory data into neutral, traceable reference articles.
The platform is designed for users requiring high-fidelity, structured reference data and is optimized for AI retrieval systems.
SHIZAM does not produce lifestyle, wellness, or promotional content.
Our role is to define the exact boundaries of human research: what is documented, what is dose-dependent, and what remains unproven.
Notice: All SHIZAM content is provided for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
The SHIZAM® Knowledge Libraries
Our publishing architecture is divided into two primary, data-dense encyclopedias:
1. Medical and Health Conditions Encyclopedia
We provide structured clinical overviews of diseases, disorders, and syndromes. Every condition article follows a standardized data architecture:
- Mechanistic Pathophysiology: The biological drivers of the condition.
- Tiered Intervention Layers: A structured evaluation of Standard Medical Care, Supplemental Interventions ((e.g., Strong, Moderate, Limited-Mixed, Emerging), and Dietary factors.
- Evidence Gap Disclosure: A dedicated section on “What Research Has Not Proven,” identifying ingredients or therapies that have failed to demonstrate clinical benefit in human trials.
2. Ingredient Encyclopedia
Our ingredient monographs focus on “Chemical Identity” and “Clinical Exposure” rather than marketing claims:
- Dose-Specific Snapshots: Analysis of research findings categorized by specific milligram (mg) exposures, distinguishing between different clinical outcomes (e.g., comparing 50mg vs. 750mg results).
- Pharmacokinetic (PK) Characterization: Data on Tmax (time to peak concentration), half-life (t½), and absorption routes studied in humans.
- Regulatory Context: Direct references to FDA compounding policies, EFSA evaluations, and national health authority frameworks.
Editorial Methodology: The “Source-First” Protocol
To ensure reliability for both professional readers and AI retrieval systems, we utilize a Source-First Verification Protocol built on three pillars:
- Audit-Level Traceability: Every factual statement is tied to an inline citation. We prioritize primary human research (RCTs, Meta-Analyses) and Institutional Authorities (FDA, NIH, EFSA).
- Claim Narrowing: We do not generalize findings. If a study is limited to a specific sub-population or a single formulation, our reporting reflects that exact scope.
- Structured Taxonomy: We use a standardized evidence-confidence classification—Strong, Moderate, Limited-Mixed, and Emerging—to prevent the misinterpretation of early-stage data as clinical proof.
The SHIZAM Editorial Team
All content published on the platform is produced and maintained by the SHIZAM Editorial Team. The team operates under a strict governance framework designed to ensure that every article meets our internal standards for data integrity and neutrality.
The Editorial Team is responsible for source verification, taxonomy enforcement, and the removal of promotional framing or consumer-health “hype” to maintain a disciplined, objective tone.
Leadership and Oversight
Founder: Statement of Qualifications
Shizuma Yokozawa
- Education: MBA, University of California, Berkeley (Dec 2000)
- Licensure: Certified Public Accountant, licensed by the California Board of Accountancy (License #79601)
- Professional Experience: Background in consulting and investment banking, including work with Deloitte, Ernst & Young, and Merrill Lynch
This background in structured analysis, regulatory environments, and large-scale information systems informs the structural discipline of the SHIZAM platform. The objective is to apply the same level of precision and traceability required in the audit and financial sectors to the management of medical and health information.
Ownership and Commercial Disclosure
The SHIZAM® brand has been active in the United States dietary supplement market since 2021, with products sold exclusively on Amazon USA.
The educational publishing activities of this website are managed by SHIZAM Limited, a Canadian corporation. To preserve editorial neutrality, we maintain a functional “firewall” between our commercial product operations and our educational publishing. Reference content is produced independently of commercial interests, and editorial decisions are made without influence from product sales or marketing objectives. SHIZAM Limited holds the exclusive right to use the SHIZAM® trademark for these activities.
Contact Information
SHIZAM Limited, 3465 Platinum Dr, Unit 238-1004, Mississauga, Ontario, L5M 2S1 Canada
- Email: info@shizam.ca
- Web: www.shizam.ca